← Back to home

PATIENTS WITH LOW HER2 EXPRESSION (IHC 1+ OR IHC 2+/ISH-) AND HER2 IHC 0 ADVANCED BREAST CANCER

Clinical trials for PATIENTS WITH LOW HER2 EXPRESSION (IHC 1+ OR IHC 2+/ISH-) AND HER2 IHC 0 ADVANCED BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH LOW HER2 EXPRESSION (IHC 1+ OR IHC 2+/ISH-) AND HER2 IHC 0 ADVANCED BREAST CANCER trials appear

Sign up with your email to follow new studies for PATIENTS WITH LOW HER2 EXPRESSION (IHC 1+ OR IHC 2+/ISH-) AND HER2 IHC 0 ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Simple blood test could guide breast cancer treatment

Knowledge-focused Not yet recruiting

This study looks at whether a blood test can predict how well the drug deruxtepruzumab works in people with advanced breast cancer that has low or ultra-low levels of a protein called HER2. Researchers will track cancer cells and HER2 levels in the blood of 100 patients during tr…

Matched conditions: PATIENTS WITH LOW HER2 EXPRESSION (IHC 1+ OR IHC 2+/ISH-) AND HER2 IHC 0 ADVANCED BREAST CANCER

Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Knowledge-focused

Last updated Jun 28, 2026 00:00 UTC

PATIENTS WITH LOW HER2 EXPRESSION (IHC 1+ OR IHC 2+/ISH-) AND HER2 IHC 0 ADVANCED BREAST CANCER

Get alerted when new PATIENTS WITH LOW HER2 EXPRESSION (IHC 1+ OR IHC 2+/ISH-) AND HER2 IHC 0 ADVANCED BREAST CANCER trials appear

Simple blood test could guide breast cancer treatment